U.S. markets open in 1 hour 40 minutes
  • S&P Futures

    4,160.00
    -4.75 (-0.11%)
     
  • Dow Futures

    33,999.00
    -17.00 (-0.05%)
     
  • Nasdaq Futures

    13,896.25
    -23.00 (-0.17%)
     
  • Russell 2000 Futures

    2,228.50
    -9.90 (-0.44%)
     
  • Crude Oil

    61.00
    -0.35 (-0.57%)
     
  • Gold

    1,787.60
    -5.50 (-0.31%)
     
  • Silver

    26.45
    -0.12 (-0.45%)
     
  • EUR/USD

    1.2060
    +0.0020 (+0.17%)
     
  • 10-Yr Bond

    1.5640
    0.0000 (0.00%)
     
  • Vix

    17.34
    -1.34 (-7.17%)
     
  • GBP/USD

    1.3902
    -0.0030 (-0.22%)
     
  • USD/JPY

    108.0500
    +0.0070 (+0.01%)
     
  • BTC-USD

    54,820.88
    -220.16 (-0.40%)
     
  • CMC Crypto 200

    1,274.17
    +11.21 (+0.89%)
     
  • FTSE 100

    6,901.02
    +5.73 (+0.08%)
     
  • Nikkei 225

    29,188.17
    +679.62 (+2.38%)
     

Bristol Myers Squibb to Participate in Raymond James Virtual 42nd Annual Institutional Investors Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Raymond James’ Virtual 42nd Annual Institutional Investors Conference, which will be webcast on Tuesday, March 2, 2021. David Elkins, Executive Vice President, Chief Financial Officer will answer questions about the company at 8:20 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005058/en/

Contacts

Bristol Myers Squibb

Media:
media@bms.com

Investor Relations:
Tim Power
609-252-7509
timothy.power@bms.com

Nina Goworek
908-673-9711
nina.goworek@bms.com